KIADIS PHARMA N.V.

Profile

Company Names

KIADIS PHARMA N.V.

Addresses

PAASHEUVELWEG 25A, AMSTERDAM, P7 1105 BP

Phone Numbers

31 (0) 20 240 52 52

 

Entity Type:

LIMITED LIABILITY COMPANY

Industry:

BIOTECHNOLOGY

Year Incorporated:

2015

State Incorporated:

NETHERLANDS

Total Amount Raised:

$18,352,460.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2019-06-05 
$18,352,460.00 
$18,352,460.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
SCOTT 
A. 
HOLMES 
EXECUTIVE OFFICER
KIADIS PHARMA N.V.
JAMES 
 
JOY 
EXECUTIVE OFFICER
KIADIS PHARMA N.V.
MARTIJN 
 
KLEIJWEGT 
DIRECTOR
PASTEURIA BIOSCIENCE, INC.   |  PROSENSA HOLDING N.V.   |  LIFE SCIENCES PARTNERS V C.V.   |  KIADIS PHARMA N.V.   |  EQT HEALTH ECONOMICS 3 COOPERATIEF U.A.
ARTHUR 
 
LAHR 
EXECUTIVE OFFICER
KIADIS PHARMA N.V.
BERNDT 
 
MODIG 
DIRECTOR
PROSENSA HOLDING N.V.   |  KIADIS PHARMA N.V.
SUBHANU 
 
SAXENA 
DIRECTOR
KIADIS PHARMA N.V.
MARK 
 
SCHAEFER 
EXECUTIVE OFFICER
TANGENT ENERGY SOLUTIONS, INC.   |  KIADIS PHARMA N.V.
OTTO 
 
SCHWARZ 
DIRECTOR
KIADIS PHARMA N.V.
DR. ROBERT 
 
SOIFFER 
DIRECTOR
KIADIS PHARMA N.V.
MARK 
 
WEGTER 
DIRECTOR
KIADIS PHARMA N.V.   |  EQT HEALTH ECONOMICS 3 COOPERATIEF U.A.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2019-06-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-06-05 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#